Phillip Read

Population-level effectiveness of rapid, targeted, high-coverage roll-out of HIV pre-exposure prophylaxis in men who have sex with men: the EPIC-NSW prospective cohort study

Andrew E. Grulich, Rebecca Guy, Janaki Amin et al. · The Lancet HIV · 2018 · 362 citations · Full text

Sexual Health, Preventive Medicine, Epidemiological Outcome +9

Sofosbuvir and velpatasvir for hepatitis C virus infection in people with recent injection drug use (SIMPLIFY): an open-label, single-arm, phase 4, multicentre trial

Jason Grebely, Olav Dalgård, Brian Conway et al. · ˜The œLancet. Gastroenterology & hepatology · 2018 · 286 citations · Full text

Hepatology, Hepatitis C, Treatment And Prevention +9

Delivering direct acting antiviral therapy for hepatitis C to highly marginalised and current drug injecting populations in a targeted primary health care setting

Phillip Read, Rebecca Lothian, Karen J. Chronister et al. · International Journal of Drug Policy · 2017 · 156 citations

Vaccination, Hepatitis C, Treatment And Prevention +6

Amyloid-β ¹¹ C-PiB-PET imaging results from 2 randomized bapineuzumab phase 3 AD trials

Enchi Liu, Mark E. Schmidt, Richard Margolin et al. · Neurology · 2015 · 149 citations · Full text

When should HAART be initiated in pregnancy to achieve an undetectable HIV viral load by delivery?

Phillip Read, Sundhiya Mandalia, Palwasha Khan et al. · AIDS · 2012 · 132 citations